Both H. pylori antibody and CagA seropositivity serostatus were found to have a decreased risk of pancreatic cancer, whereas CagA-negative H. pylori seropositivity showed an increased risk to some extent. This evidence concerns the gene S100A8 and familial pancreatic carcinoma.